Literature DB >> 28967501

Intra-Individual Comparison between 2-D Shear Wave Elastography (GE System) and Virtual Touch Tissue Quantification (Siemens System) in Grading Liver Fibrosis.

Rosa M S Sigrist1, Ahmed El Kaffas1, R Brooke Jeffrey1, Jarrett Rosenberg1, Jürgen K Willmann2.   

Abstract

Ultrasound-based shear wave elastography (SWE) has recently gained substantial attention for non-invasive assessment of liver fibrosis. The purpose of this study was to perform an intra-individual comparison between 2-D shear wave elastography (2-D-SWE with a GE system) and Virtual Touch Tissue Quantification (VTTQ with a Siemens system) to assess whether these can be used interchangeably to grade fibrosis. Ninety-three patients (51 men, 42 women; mean age, 54 y) with liver disease of various etiologies (hepatitis B virus = 47, hepatitis C virus = 22; alcohol = 6, non-alcoholic steatohepatitis = 5, other = 13) were included. Using published system-specific shear wave speed cutoff values, liver fibrosis was classified into clinically non-significant (F0/F1) and significant (≥F2) fibrosis. Results indicated that intra-modality repeatability was excellent for both techniques (GE 2-D-SWE: intra-class correlation coefficient = 0.89 [0.84-0.93]; VTTQ: intra-class correlation coefficient = 0.90 [0.86-0.93]). Intra-modality classification agreement for fibrosis grading was good to excellent (GE 2-D-SWE: κ = 0.65, VTTQ: κ = 0.82). However, inter-modality agreement for fibrosis grading was only fair (κ = 0.31) using published system-specific shear wave speed cutoff values of fibrosis. In conclusion, although both GE 2-D-SWE and Siemens VTTQ exhibit good to excellent intra-modality repeatability, inter-modality agreement is only fair, suggesting that these should not be used interchangeably.
Copyright © 2017 World Federation for Ultrasound in Medicine and Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrosis; GE 2-D shear wave elastography; Liver; Ultrasound elastography; Virtual Touch Tissue Quantification

Mesh:

Year:  2017        PMID: 28967501     DOI: 10.1016/j.ultrasmedbio.2017.08.934

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

1.  Point Shear Wave Elastography Using Machine Learning to Differentiate Renal Cell Carcinoma and Angiomyolipoma.

Authors:  Hersh Sagreiya; Alireza Akhbardeh; Dandan Li; Rosa Sigrist; Benjamin I Chung; Geoffrey A Sonn; Lu Tian; Daniel L Rubin; Jürgen K Willmann
Journal:  Ultrasound Med Biol       Date:  2019-05-25       Impact factor: 2.998

2.  Shear wave elastography-based ultrasomics: differentiating malignant from benign focal liver lesions.

Authors:  Wei Wang; Jian-Chao Zhang; Wen-Shuo Tian; Li-Da Chen; Qiao Zheng; Hang-Tong Hu; Shan-Shan Wu; Yu Guo; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Long-Zhong Liu; Si-Min Ruan
Journal:  Abdom Radiol (NY)       Date:  2020-06-20

3.  Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases.

Authors:  Lulu Yang; Wenwu Ling; Du He; Changli Lu; Lin Ma; Lin Tang; Yan Luo; Shigao Chen
Journal:  Quant Imaging Med Surg       Date:  2021-04

4.  Technical Performance of Two-Dimensional Shear Wave Elastography for Measuring Liver Stiffness: A Systematic Review and Meta-Analysis.

Authors:  Dong Wook Kim; Chong Hyun Suh; Kyung Won Kim; Junhee Pyo; Chan Park; Seung Chai Jung
Journal:  Korean J Radiol       Date:  2019-06       Impact factor: 3.500

Review 5.  Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.

Authors:  Amir M Pirmoazen; Aman Khurana; Ahmed El Kaffas; Aya Kamaya
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

6.  Assessment of liver fibrosis using 2-dimensional shear wave elastography: a prospective study of intra- and inter-observer repeatability and comparison with point shear wave elastography.

Authors:  Jeongin Yoo; Jeong Min Lee; Ijin Joo; Jeong Hee Yoon
Journal:  Ultrasonography       Date:  2019-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.